Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Infanrix TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: diphtheria + tetanus + pertussis 3 component vaccine, diphtheria + tetanus vaccine
Brand name
(ARTG)
: INFANRIX diphtheria toxoid / pertactin / pertussis filamentous haemagglutinin / pertussis toxoid / tetanus toxoid 0.5mL injection syringeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Infanrix is indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole-cell) vaccine. INDICATIONS AS OF 8TH JANUARY 1997 - Infanrix (DTPa) is indicated for active primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. Infanrix (DTPa) is also indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria,tetanus and pertussis (whole-cell or acellular) vaccine.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Intramuscular
- White turbid suspension
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 0.5mL x syringe with needle (Aust L 19009) x 1 pack
- 0.5mL x syringe x 1 pack
- 10 x syringe pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient diphtheria + tetanus + pertussis 3 component vaccine
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Vaxelis | NCIRS
DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) – frequently asked questions NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points There are two hexavalent combination vaccines – Vaxelis® and Infanrix hexa® – available on the National Immunisation Program (NIP) that protect against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, polio and Haemophilus influenzae type b (Hib)
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Japanese encephalitis | NCIRS
Japanese encephalitis NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Japanese encephalitis (JE) situation in Australia has been declared a Communicable Disease Incident of National Significance as of March 2022
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
COVID-19 vaccines: Frequently asked questions (FAQs) | NCIRS
COVID-19 vaccines: Frequently asked questions (FAQs) COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points COVID-19 is a disease caused by the SARS-CoV-2 virus
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Tetanus vaccine | Australian Government Department of Health, Disability and Ageing
Information about tetanus vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the tetanus vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Diphtheria vaccine | Australian Government Department of Health, Disability and Ageing
Information about diphtheria vaccines, who it is recommended for, how and where to get vaccinated. If you’re eligible, you can get the diphtheria vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Whooping cough (pertussis) vaccine | Australian Government Department of Health, Disability and Ageing
Information about the whooping cough vaccine, who they are recommended for and possible side effects. If you're eligible, you can get the whooping cough vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Pertussis (whooping cough) | The Australian Immunisation Handbook
Information about pertussis (whooping cough) disease, vaccines and recommendations for vaccination from the Australian Immunisation Handbook
Read more on Australian Government Department of Health, Disability and Ageing website
Polio (poliomyelitis) vaccine | Australian Government Department of Health, Disability and Ageing
Information about polio vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the polio vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Hepatitis B vaccine | Australian Government Department of Health, Disability and Ageing
Information about hepatitis B vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the hepatitis B vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Hib (Haemophilus influenzae type b) vaccine | Australian Government Department of Health, Disability and Ageing
Information about Hib vaccines, who it is recommended for, how and where to get vaccinated. Eligible people can get the Hib vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Top results
Supporting conversations about vaccinations with Aboriginal and Torres Strait Islander people | NCIRS
Supporting conversations about vaccinations with Aboriginal and Torres Strait Islander people NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety This page is for immunisation providers (e
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Pertussis Guide for Health Care Professionals - Immunisation Coalition
Pertussis is a highly contagious bacterial infection affecting the respiratory system, that can cause severe illness and death.
Read more on Immunisation Coalition website
